The "reset button" revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients.
Frederik A VerburgMarkus LusterLuca GiovanellaMichael LassmannCarlo ChiesaNicolas ChouinGlenn Fluxnull nullPublished in: European journal of nuclear medicine and molecular imaging (2017)